Pregled bibliografske jedinice broj: 815692
NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157 in rats and guinea pigs
NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157 in rats and guinea pigs // European journal of pharmacology, 771 (2016), 211-219 doi:10.1016/j.ejphar.2015.12.016 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 815692 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157 in rats and guinea pigs
Autori
Kokot, Antonio ; Zlatar, Mirna ; Stupnišek, Mirjana ; Drmić, Domagoj ; Radić, Radivoje ; Včev, Aleksandar ; Seiwerth, Sven ; Sikirić, Predrag
Izvornik
European journal of pharmacology (0014-2999) 771
(2016);
211-219
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
BPC 157 ; NO system ; miosis ; atropine ; rats ; guinea pigs
Sažetak
We revealed an immediate and hours-lasting particular NO-specific parallel miotic effect of L-NAME and L-arginine in rats and guinea pigs and a stable gastric pentadecapeptide BPC 157 157-particular effect versus that of atropine-induced mydriasis while examining the NO system role in the normal pupils responses and pupils with atropine-induced mydriasis. We also assessed the responses to BPC 157 and its possible modulation of the changes caused by L-NAME/L-arginine and atropine. We administered locally (two drops/eye) or systemically (intraperitoneally/kg) [BPC 157 (0.4µg/eye ; 10µg, 10ng, 10pg/kg), L-NAME (0.1mg/eye ; 5mg/kg), and L-arginine (2mg/eye ; 100mg/kg) alone and combined] at 3 min prior to assessment (normal pupils) or alternatively at maximal 1% atropine-induced mydriasis (30 min after two drops were administered to each eye). L-NAME/L-arginine. Normal pupil. L-NAME-miosis and L-arginine-miosis shortened and attenuated each other’s responses when combined (L-NAME+L-arginine) (except with guinea pigs treated locally) and were thereby NO-specific. Atropine-pupil. Both L-NAME and L-arginine counteracted atropine-induced mydriasis. With few exceptions, the atropine+L-NAME+L-arginine-animals showed a consistent shift toward the left. BPC 157. Normal pupil. Always, BPC 157 alone (both species ; locally ; systemically ; all regimens) did not affect normal pupils. Despite specific exceptions, BPC 157 distinctively affects L-arginine-miosis (prolongation) and L-NAME-miosis (shortening). When L-arginine and L-NAME were combined (L-NAME+L-arginine+BPC 157), the effect was less pronounced. Atropine-pupil. BPC 157 alone counteracted atropine-induced mydriasis. With few exceptions (when administered with L-NAME or L-arginine or L-NAME+L-arginine), BPC 157 augments their counteracting effects. Thus, along with its L-NAME/L-arginine effects, BPC 157 participates in ocular control, potentially via NO-mediated and cholinergic mechanisms.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
108-1083570-3635 - Pentadekapeptid BPC 157 - daljnja istraživanja (Sikirić, Predrag, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Medicinski fakultet, Osijek
Profili:
Ivan Domagoj Drmić
(autor)
Radivoje Radić
(autor)
Predrag Sikirić
(autor)
Antonio Kokot
(autor)
Mirjana Stupnišek
(autor)
Aleksandar Včev
(autor)
Sven Seiwerth
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- BIOSIS Previews (Biological Abstracts)
- EMBASE (Excerpta Medica)
- MEDLINE
- SCOPUS
- Pascal et Francis (INST-CNRS)
- Reference Update
- Unlisted Drugs